Enterprise League logo

Product

211 At-DGT-77

BIOTECHNOLOGY

bydGenThera

United States (US)

ABOUT THE PRODUCT

A small molecule 211 At-DGT-77 demonstrates compelling efficacy in vivo in breast cancer xenograft tumorized mice, showing approximately 100% tumor growth inhibition (TGI) at four weeks post-dosing.

Information is owner-confirmed

Last updated 1 month ago

Price range
N/A

Other products/services from dGenThera

Default Product Image
131 I-DGT-207
Biotechnology

N/A

dGenThera Logo

dGenThera

United States (US)